FDA Approves Roche and Eli Lilly Blood Test for Alzheimer's Biomarkers

The FDA authorized a new blood test by Roche and Eli Lilly to detect Alzheimer's disease indicators in adults with cognitive decline.

Carried by 3 publishers across 3 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.